Within the scope of the work, 50 different parameters of patients with loco-regional lung adenocarcinoma were examined, which were operated on at the lung clinic Gauting, also part of the DZL. Lung adenocarcinoma, a special form of lung cancer, has been increasingly present in recent years in younger patients, women, and especially non-smokers, so that accurate characterization of this disease is of great importance to establish new therapeutic options. With the work of Dr. med. Klotz, a new score for predicting survive was also created al.
The 7th DZL Annual Meeting took place from 8 to 9 February in Bad Nauheim. Here, 480 scientists, physicians and young researchers exchanged views on their projects in the field of lung research. The DZL is an association of leading university and non-university institutions dedicated to the research of respiratory diseases. The aim of the DZL is to jointly develop new approaches for the prevention, diagnosis and treatment of widespread lung diseases in a translational research approach.
Further information at: www.dzl.de